R&D News | pharmaphorum

News

eyeDNA plans pivotal trial of retinitis pigmentosa therapy

Two-year data with eyeDNA Therapeutics’ gene therapy for retinitis pigmentosa (RP), an inherited form of blindness, has prompted the biotech to seek discussions with regul

News

Double ApoE4 gene a 'distinct form' of early Alzheimer’s

Having two copies of the ApoE4 gene is not just a risk factor for the development of Alzheimer’s, but is a likely cause of the disease, according to researchers in Spain.

News

Citi analyst Andrew Baum to head Pfizer strategy team

Pfizer will draw on the expertise of Citi analyst Andrew Baum when it comes to portfolio management and capital deployment, naming him chief strategy and innovation office

News

Boehringer raises hope of diabetic macular ischaemia therapy

Boehringer Ingelheim says it may have found the first therapy for diabetic macular ischaemia (DMI), a common and irreversible complication of the eye in people with diabet

News

Top charities team up with $300m for climate, health equity

The Novo Nordisk Foundation, the Bill & Melinda Gates Foundation, and Wellcome have joined forces to tackle some of the most pressing threats to human health and wellb

News

Apple gets FDA okay to use AFib tool in clinical trials

The atrial fibrillation (AFib) detection feature on Apple Watch devices has become the first digital health technology to be qualified under a programme recently introduce

eyeDNA plans pivotal trial of retinitis pigmentosa therapy

Double ApoE4 gene a 'distinct form' of early Alzheimer’s

Citi analyst Andrew Baum to head Pfizer strategy team

Boehringer raises hope of diabetic macular ischaemia therapy

Top charities team up with $300m for climate, health equity

Apple gets FDA okay to use AFib tool in clinical trials

Bankruptcy threat looms as Quince runs out of options

How to meet your physicians where they are online

News

Editor's Picks